Adherium Ltd. (ASK:ADR) said today that its Smartinhaler was chosen for the myAirCoach program as a part of the European Union’s Horizon 2020 Framework for Research and Innovation. The Horizon 2020 program is the largest EU research and innovation program ever established, with €80 billion (nearly $85 billion) of funding available from 2014 until 2020.
The myAirCoach program was developed to evaluate if home monitoring and mobile health technology can be predictive for patients who suffer from asthma. The program’s primary goals is to help asthma patients manage their symptoms and enhance the adherence and effectiveness of their prescribed regimens.
Get the full story at our sister site, Drug Delivery Business News.
The post Adherium’s smart inhaler tech chosen for EU mobile health program appeared first on MassDevice.